Author:
Le Viet H.,Franko Jan,Paz Benjamin I.,Singh Gagandeep,Fakih Marwan,Chung Vincent
Reference19 articles.
1. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal;Ballehaninna;J. Gastrointest. Oncol,2012
2. Ca19-9 and pancreatic cancer: is it really that good?;Morris-Stiff;J. Gastrointest. Oncol.,2012
3. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy;Hartwig;Ann. Surg. Oncol,2013
4. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?;Kim;J. Gastroenterol. Hepatol.,2009
5. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer;Kondo;Ann. Surg. Oncol.,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献